Saxenda pen instructions on TikTok: what the video gets right and wrong

What's this video probably claiming?

Based on the caption, @conqueryourweight is walking viewers through how to use the Saxenda (liraglutide) injection pen, likely covering steps like dialing the dose, attaching a needle, priming the device, selecting an injection site, and disposing of the needle safely. These how-to videos are extremely common in the GLP-1 space, and on the surface they seem helpful. The problem is that "step-by-step" pen instruction content almost always glosses over the dose escalation schedule, which is not optional fine print. It is the single most important variable determining whether a patient tolerates liraglutide or spends three weeks vomiting. Without that context, a technically correct demonstration can still leave viewers underinformed about what actually matters clinically.

What does the science actually show?

Saxenda is liraglutide at 3.0 mg daily, approved by the FDA in 2014 for chronic weight management in adults with a BMI of 30 or above, or 27 with a weight-related comorbidity. The SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, New England Journal of Medicine) randomized 3,731 adults and found that 63.2% of liraglutide-treated participants lost at least 5% of body weight versus 27.1% on placebo at 56 weeks. Mean weight loss was 8.4 kg on liraglutide versus 2.8 kg on placebo. Critically, the trial used a specific titration schedule: starting at 0.6 mg per day for one week, then increasing by 0.6 mg weekly until reaching 3.0 mg. That ramp-up is not a suggestion. It exists because gastrointestinal side effects, primarily nausea, vomiting, and diarrhea, affect a substantial portion of users and are significantly reduced when the dose is escalated slowly.

Where does the social media noise diverge from clinical reality?

TikTok pen tutorials tend to make injection technique look like the main event. It is not. The pen itself is relatively intuitive. What patients consistently struggle with is managing expectations around side effects, understanding that the maintenance dose of 3.0 mg takes five weeks to reach, and knowing what symptoms should prompt them to call a provider versus just push through. A 2022 analysis by Wilding et al. in Diabetes, Obesity and Metabolism found that discontinuation rates in real-world liraglutide use were substantially higher than in trials, with tolerability issues as the leading reason. When a TikTok video focuses on the mechanics of the pen without addressing escalation, side effect thresholds, or when to contact a clinician, it is optimizing for engagement over safety. That gap is not harmless.

What should you actually know?

If you are starting Saxenda, the pen mechanics will take you about ten minutes to learn. The five-week titration schedule and your personal side effect tolerance are what determine whether you stay on the medication long enough to see results. Liraglutide also has a black box warning for thyroid C-cell tumors observed in rodent studies, and it is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. These are not rare edge cases you can skip because a TikTok creator seems confident. Pancreatitis is another documented risk. According to the prescribing information and the Pi-Sunyer 2015 trial, patients should be counseled to report persistent severe abdominal pain immediately. None of this appears likely to feature in a 60-second pen tutorial, and that absence matters.

The bottom line on GLP-1 content like this

Pen instruction videos are not inherently bad. They can reduce anxiety for new patients and improve technique. But they sit in a regulatory grey zone where a creator demonstrating a prescription injectable to 24,000 viewers is providing what functions as medical guidance without a clinical relationship or liability. FormBlends recommends treating this type of content as a supplement to, not a replacement for, instructions from your prescribing provider or pharmacist. If the video does not mention dose escalation, contraindications, or when to seek medical attention, it is incomplete regardless of how accurate the physical demonstration is. Watch it, then call your provider.